RS63093B1 - Terapija matičnim ćelijama kod patoloških stanja endometrijuma - Google Patents

Terapija matičnim ćelijama kod patoloških stanja endometrijuma

Info

Publication number
RS63093B1
RS63093B1 RS20220339A RSP20220339A RS63093B1 RS 63093 B1 RS63093 B1 RS 63093B1 RS 20220339 A RS20220339 A RS 20220339A RS P20220339 A RSP20220339 A RS P20220339A RS 63093 B1 RS63093 B1 RS 63093B1
Authority
RS
Serbia
Prior art keywords
stem cell
cell therapy
endometrial
pathologies
endometrial pathologies
Prior art date
Application number
RS20220339A
Other languages
English (en)
Inventor
Carlos Simon
Javier Santamaria
Antonio Pellicer
Irene Cervello
Original Assignee
Asherman Therapy S L U
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asherman Therapy S L U filed Critical Asherman Therapy S L U
Publication of RS63093B1 publication Critical patent/RS63093B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
RS20220339A 2014-06-17 2015-06-05 Terapija matičnim ćelijama kod patoloških stanja endometrijuma RS63093B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462013121P 2014-06-17 2014-06-17
EP19169309.2A EP3569697B8 (en) 2014-06-17 2015-06-05 Stem cell therapy in endometrial pathologies

Publications (1)

Publication Number Publication Date
RS63093B1 true RS63093B1 (sr) 2022-04-29

Family

ID=54329860

Family Applications (2)

Application Number Title Priority Date Filing Date
RSP20190913 RS59210B1 (sr) 2014-06-17 2015-06-05 Terapija matičnim ćelijama kod patoloških stanja endometrijuma
RS20220339A RS63093B1 (sr) 2014-06-17 2015-06-05 Terapija matičnim ćelijama kod patoloških stanja endometrijuma

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RSP20190913 RS59210B1 (sr) 2014-06-17 2015-06-05 Terapija matičnim ćelijama kod patoloških stanja endometrijuma

Country Status (21)

Country Link
US (1) US11129851B2 (sr)
EP (3) EP3158057B1 (sr)
JP (2) JP6920062B2 (sr)
CN (2) CN107073040A (sr)
AU (1) AU2015275798B2 (sr)
BR (1) BR112016029558A2 (sr)
CA (1) CA2952559C (sr)
CY (2) CY1122615T1 (sr)
DK (2) DK3569697T3 (sr)
ES (2) ES2910306T3 (sr)
HR (2) HRP20220419T1 (sr)
HU (2) HUE044823T2 (sr)
LT (2) LT3569697T (sr)
MX (1) MX2016016756A (sr)
PL (2) PL3158057T3 (sr)
PT (2) PT3569697T (sr)
RS (2) RS59210B1 (sr)
RU (1) RU2725006C2 (sr)
SI (2) SI3569697T1 (sr)
TR (1) TR201910410T4 (sr)
WO (1) WO2015193737A1 (sr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
US10006091B2 (en) 2012-06-06 2018-06-26 Fundació Institut De Recerca Biomèdica (Irb Barcelona) Method for the diagnosis, prognosis and treatment of lung cancer metastasis
US10119171B2 (en) 2012-10-12 2018-11-06 Inbiomotion S.L. Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
BR112015008255B1 (pt) 2012-10-12 2023-02-28 Inbiomotion S.L Métodos in vitro para diagnóstico ou prognóstico de metástase óssea em um indivíduo com câncer de próstata e método para classificar um indivíduo que sofre de câncer de próstata em uma coorte
CA2903306A1 (en) 2013-03-15 2014-09-18 Fundacio Institut De Recerca Biomedica (Irb Barcelona) Method for the diagnosis, prognosis and treatment of metastatic cancer
PL3158057T3 (pl) 2014-06-17 2020-05-18 Igenomix S.L. Terapia komórkami macierzystymi w patologiach endometrium
EP3474866A4 (en) * 2016-06-23 2020-02-26 Tithon Biotech, Inc. CELLS EXPRESSING THE PARATHYROID HORMONE RECEPTOR 1 AND USES THEREOF
RU2699029C1 (ru) * 2018-12-10 2019-09-03 Частное образовательное учреждение дополнительного профессионального образования "Академия медицинского образования имени Федора Ивановича Иноземцева" (ЧОУ ДПО "Академия медицинского образования им. Ф.И. Иноземцева") Способ использования мезенхимальных стволовых клеток для улучшения состояния рубца на матке
RU2741621C1 (ru) * 2020-09-25 2021-01-28 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Способ лечения внутриматочных синехий
CN117979980A (zh) 2021-07-23 2024-05-03 车医科学大学校产学协力团 用于预防或治疗阿谢曼综合征的包含分离的线粒体作为活性成分的药物组合物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE140868T1 (de) 1989-05-05 1996-08-15 North Sydney Area Health Serv Steigerung der fruchtbarkeit
US6979533B2 (en) 1992-06-12 2005-12-27 The Trustees Of The University Of Pennsylvania Determination of endometrial receptivity toward embryo implantation
CA2203718A1 (en) 1997-04-25 1998-10-25 University Of British Columbia Cadherin-11 as an indicator of viable pregnancy
IL127896A0 (en) 1998-12-31 1999-10-28 Gail Laster A novel treatment for preeclampsia and related diseases
CA2400065A1 (en) 2000-03-08 2001-09-13 Harvey J. Kliman Methods of diagnosing and monitoring endometrial glandular development
WO2001089548A2 (en) 2000-05-24 2001-11-29 Schering Aktiengesellschaft Pharmaceutical use of fibulin-1
US6780594B2 (en) 2000-09-25 2004-08-24 Schering Aktiengesellschaft Method for in vitro diagnosis of endometriosis
AUPR673001A0 (en) 2001-07-31 2001-08-23 Prince Henry's Institute Of Medical Research Pregnancy-related enzyme activity
DE10139874A1 (de) 2001-08-10 2003-04-30 Schering Ag Humane Mater-Proteine
GB0201284D0 (en) 2002-01-21 2002-03-06 Isis Innovation Screening methods for contraceptive and fertility agents
US20030186300A1 (en) 2002-03-20 2003-10-02 Ali Akoum Methods and products for modulation of reproductive processes and for diagnosis, prognostication and treatment of related conditions
US20040005612A1 (en) 2002-05-14 2004-01-08 Giudice Linda C. Endometrial genes in endometrial disorders
DE50304970D1 (de) 2002-08-02 2006-10-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
EP1579007B1 (de) 2002-12-21 2015-05-27 Universität Leipzig Verfahren und mittel zur bestimmung von bestimmten zuständen bzw. veränderungen im uterusepithel und im epithel anderer organe
US20060286555A1 (en) 2003-08-21 2006-12-21 Van Beuningen Marinus G J Microarray support for bioprobe synthesis
JP2007504807A (ja) 2003-09-08 2007-03-08 ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 培養培地にプロスタグランジン又はプロスタグランジン類似物を補足することによってインビトロ胚発生を高めるための方法及び組成
EP1670902A4 (en) 2003-09-08 2008-05-07 Univ Texas METHOD AND COMPOSITION FOR ENHANCING IN VITRO EMBRYONIC DEVELOPMENT BY ENRICHING A CULTURE MEDIUM COMPRISING PROSTAGLANDIN OR PROSTAGLANDIN ANALOGUE
ATE476525T1 (de) 2003-12-23 2010-08-15 Mount Sinai Hospital Corp Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern
JP2008501035A (ja) 2004-05-28 2008-01-17 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 妊孕性関連障害の治療におけるｉｌ−１７の使用
WO2007113721A2 (en) * 2006-03-31 2007-10-11 Koninklijke Philips Electronics, N.V. Systems and methods for cell measurement utilizing ultrashort t2* relaxometry
JP2007278750A (ja) 2006-04-04 2007-10-25 Ono Pharmaceut Co Ltd プロスタグランジン類及びその類縁体の定量方法
WO2008036374A2 (en) * 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
GB0703683D0 (en) * 2007-02-26 2007-04-04 Ark Therapeutics Ltd The treatment of complications in pregnancy
US9259233B2 (en) * 2007-04-06 2016-02-16 Hologic, Inc. Method and device for distending a gynecological cavity
WO2009143633A1 (en) 2008-05-30 2009-12-03 Institut De Recherches Cliniques De Montreal Pcsk9 inhibitors and methods of use thereof
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
WO2013166281A1 (en) * 2012-05-02 2013-11-07 Cedars-Sinai Medical Center Bi-functional compositions for targeting cells to diseased tissues and methods of using same
EP2348318A1 (en) 2010-01-21 2011-07-27 Equipo Ivi Investigación, S.L. Diagnostic method for endometrial receptivity
ES2662571T3 (es) 2011-10-21 2018-04-09 Institut National De La Santé Et De La Recherche Médicale (Inserm) Métodos de evaluación de la receptividad endometrial de una paciente tras una hiperestimulación ovárica controlada
WO2013081554A1 (en) 2011-11-30 2013-06-06 Agency For Science, Technology And Research Gm1 ganglioside to annexin v microparticle polypeptide ratio for biological monitoring
CN104412107B (zh) 2012-06-27 2018-06-08 弗·哈夫曼-拉罗切有限公司 用sFlt-1/PlGF或内皮糖蛋白/PlGF比值来排除先兆子痫在某时期内发病的手段和方法
RU2515475C1 (ru) * 2012-11-15 2014-05-10 Федеральное государственное бюджетное учреждение науки ИНСТИТУТ ЦИТОЛОГИИ РОССИЙСКОЙ АКАДЕМИИ НАУК Способ стимуляции образования децидуальной оболочки эндометрия в эксперименте
CA2943284A1 (en) 2014-03-21 2015-11-05 Igenomix S.L. Early detection of preeclampsia
PL3158057T3 (pl) 2014-06-17 2020-05-18 Igenomix S.L. Terapia komórkami macierzystymi w patologiach endometrium

Also Published As

Publication number Publication date
SI3158057T1 (sl) 2019-10-30
SI3569697T1 (sl) 2022-05-31
DK3158057T3 (da) 2019-07-29
PL3158057T3 (pl) 2020-05-18
JP2017522288A (ja) 2017-08-10
PL3569697T3 (pl) 2022-07-04
AU2015275798B2 (en) 2021-03-25
HRP20191240T1 (hr) 2019-11-01
ES2736117T3 (es) 2019-12-26
RU2017101147A (ru) 2018-07-17
US20170128492A1 (en) 2017-05-11
WO2015193737A1 (en) 2015-12-23
CA2952559C (en) 2023-01-24
LT3158057T (lt) 2019-09-25
BR112016029558A2 (pt) 2017-08-22
HUE044823T2 (hu) 2019-11-28
RU2017101147A3 (sr) 2019-02-06
CY1125938T1 (el) 2024-02-16
HUE058328T2 (hu) 2022-07-28
PT3569697T (pt) 2022-05-02
DK3569697T3 (da) 2022-04-04
CN107073040A (zh) 2017-08-18
ES2910306T3 (es) 2022-05-12
TR201910410T4 (tr) 2019-08-21
EP3569697B8 (en) 2022-04-27
CY1122615T1 (el) 2021-03-12
CN116747241A (zh) 2023-09-15
HRP20220419T1 (hr) 2022-05-27
EP3569697B1 (en) 2022-01-05
CA2952559A1 (en) 2015-12-23
RU2725006C2 (ru) 2020-06-29
RS59210B1 (sr) 2019-10-31
LT3569697T (lt) 2022-04-25
PT3158057T (pt) 2019-07-19
EP3158057A1 (en) 2017-04-26
JP6920062B2 (ja) 2021-08-18
EP3158057B1 (en) 2019-04-17
US11129851B2 (en) 2021-09-28
MX2016016756A (es) 2017-11-02
JP2020138984A (ja) 2020-09-03
EP4012023B1 (en) 2024-05-15
AU2015275798A1 (en) 2017-02-02
EP4012023A1 (en) 2022-06-15
EP3569697A1 (en) 2019-11-20

Similar Documents

Publication Publication Date Title
IL274903A (en) cell
LT3569697T (lt) Kamieninių ląstelių terapija endometriumo patologijų atvejais
HK1231632A1 (zh) 電池
SG11201610831PA (en) Lithium-sulphur battery
PL3134724T3 (pl) Komórka elektrochemiczna
SG11201607925SA (en) Improved stem cell composition
SG11201609055RA (en) Integrated single cell sequencing
PT3157504T (pt) Composições estimuladoras das células estaminais
GB201411985D0 (en) Battery
HUE042287T2 (hu) Lítium-kén cella
SG10201403640XA (en) Stem cells
GB201416493D0 (en) Polypeptides for use in therapy
GB201406700D0 (en) Cervix cells
ZA201505928B (en) Built in gas-fired braii unit
GB201416750D0 (en) Cell preparation
GB201411798D0 (en) Electrochemical cell
GB201406606D0 (en) Improvements in transformer design
GB201410934D0 (en) T cell